Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/31/2002US20020160403 huBUB3 gene involved in human cancers
10/31/2002US20020160395 Detection of survivin in the biological fluids of cancer patients
10/31/2002US20020160394 Regulation of transthyretin to treat obesity
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160390 Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder
10/31/2002US20020160388 Compositions and methods relating to lung specific genes and proteins
10/31/2002US20020160387 Compositions and methods relating to ovary specific genes and proteins
10/31/2002US20020160386 Methods of using transporter-like molecules to treat pain and pain-related disorders
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160383 Use of nucleic acid analogues in diagnostics and analytical procedures
10/31/2002US20020160382 Detection cell differentiation gene expression
10/31/2002US20020160379 Gapped 2' modified oligonucleotides
10/31/2002US20020160378 Detection hybrids; cell differentiation; gene expression;
10/31/2002US20020160377 In situ translation; generating fusion proteins; libraries
10/31/2002US20020160375 Generating tissue; cell differentiation
10/31/2002US20020160374 Fusion protein; genetic engineering; binding to antibodies
10/31/2002US20020160372 Veterinary medicine; screening animal for litter size; polymerase chain reaction; amplification
10/31/2002US20020160371 56739, a novel CUB domain containing protein and uses thereof
10/31/2002US20020160365 Compositions and methods for the early diagnosis of ovarian cancer
10/31/2002US20020160355 Methods and reagents for modulating TGF-beta superfamily signalling
10/31/2002US20020160024 Modulating movement of a cell within or to the skin of a mammal by administering to mammal an effective amount of an antagonist an agonist of CTACK, an antagonist or agonist of Vic chemokines
10/31/2002US20020160020 Enterohemorrhagic escherichia coli vaccine
10/31/2002US20020160019 Providing peptide that bears a DR motif corresponding to a Class II HLA molecule, testing peptide for binding affinity to a Class II HLA DR molecule, whereupon an IC50 binding affinity is determined
10/31/2002US20020160018 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus
10/31/2002US20020160017 Malaria vaccine
10/31/2002US20020160016 Modified surface antigen
10/31/2002US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002US20020160014 Cancer immunotherapy, particularly with immunotherapeutic combinations and treatment methods to prevent tumor cell growth and/or to eliminate those cells
10/31/2002US20020160013 Used in diagnosis and therapy of diseases that involve inadequate or inappropriate receptor response as well as in the screening of drug candidates that affect surface expression of receptors
10/31/2002US20020160012 Vaccine chip technology exploiting immunostimulating fragment of TGF-BETA
10/31/2002US20020160009 For treatment of disseminated candidiasis due to infection by C. albicans; composition includes phosphomannan of C. albicans
10/31/2002US20020160006 Methods of treating lymphoma and leukemia
10/31/2002US20020160004 Antibodies against flt3-ligand
10/31/2002US20020160002 SseCKS gene encodes a substrate of protein kinase C that functions as both a mitogenic regulator as well as a tumor suppressor
10/31/2002US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002US20020159998 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
10/31/2002US20020159991 Modulation of Abeta levels by beta-secretase BACE2
10/31/2002US20020159989 Peptide that interacts with thrombospondin 2 and inhibits matrix metalloproteinase 9 (MMP-9) activity, useful for treating diseases, such as cancer and arthritis
10/31/2002US20020159979 Adeno- associated virus inverted terminal repeats flanking DNA sequences encoding an immunodeficiency virus protein operably linked to a promoter and polyadenylation sequences
10/31/2002US20020159977 Administering a recombinant adeno-associated virion into human suffering from hemophilia such that factor VIII nuclotide sequence are expressed at a level which provide therapeutically effective amount in the patient
10/31/2002US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002US20020159972 Nucleic acids encoding IL13 mutants
10/31/2002US20020159970 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/31/2002US20020159969 A MUC-1 mucin (a high molecular weight glycoprotein) derivative, containing specific amino acid sequence and less than 60 amino acid in length, linked to a cytokine; clinically significant marker for cancers
10/31/2002US20020159958 Methods for producing immunoglobulins containing protection proteins in plants and their use
10/31/2002DE10121283A1 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen Methods and vectors for amplification or expression of the desired nucleic acid sequences in plants
10/31/2002DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002CA2807478A1 Use of follistatin to increase muscle mass
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445627A1 Methods of using a hyaluronan receptor
10/31/2002CA2445258A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002CA2445197A1 T1r3 a novel taste receptor
10/31/2002CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002CA2445171A1 A 150 kda tgf-beta 1 accessory receptor acting as a negative modulator of tgf-beta signaling
10/31/2002CA2445011A1 Transformed silkworm producing human collagen
10/31/2002CA2444709A1 Compositions and methods to control bleeding
10/31/2002CA2444696A1 Polynucleotides and polypeptides associated with the nf-kb pathway
10/31/2002CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002CA2444683A1 Antimicrobial polypeptides and their uses
10/31/2002CA2444680A1 Binding molecules for fc-region polypeptides
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444654A1 Molecular sequence of pig endogenous retrovirus receptors and methods of use
10/31/2002CA2444617A1 Production of genetically modified plants with puroindolines
10/31/2002CA2444602A1 Anti-obesity polypeptides
10/31/2002CA2444594A1 Sprr1a and axonal regeneration
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444195A1 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs
10/31/2002CA2444006A1 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002CA2443913A1 Interleukin-1 homolog zil1a7
10/31/2002CA2443781A1 Core-glycosylated hcv envelope proteins
10/31/2002CA2443770A1 Proteins and nucleic acids encoding same
10/31/2002CA2443757A1 In vivo incorporation of unnatural amino acids
10/31/2002CA2443740A1 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2441540A1 Replikin peptides and uses thereof
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2439690A1 Modified interferon alpha with reduced immunogenicity
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1253201A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
10/30/2002EP1253200A1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
10/30/2002EP1253197A1 Attenuated recombinant rabies virus and live vaccines thereof
10/30/2002EP1252337A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252330A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/30/2002EP1252329A2 Hypocretin and hypocretin receptors in regulation of sleep and related disorders
10/30/2002EP1252325A1 Compositions and methods for inhibition of hiv-1 infection
10/30/2002EP1252319A2 Combinatorial protein domains
10/30/2002EP1252315A2 Method for the production of a protein
10/30/2002EP1252314A4 Identification and expression of human kir5.1
10/30/2002EP1252314A2 Identification and expression of human kir5.1
10/30/2002EP1252313A2 Use of dendroaspin as a vehicle for non-dendroaspin domains
10/30/2002EP1252312A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252311A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels
10/30/2002EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof
10/30/2002EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
10/30/2002EP1252305A2 Full-length human cdnas encoding potentially secreted proteins
10/30/2002EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252297A1 Nucleic acids, proteins, and antibodies